These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25791931)

  • 1. Intrapatient diversity of Achromobacter spp. involved in chronic colonization of Cystic Fibrosis airways.
    Dupont C; Michon AL; Jumas-Bilak E; Nørskov-Lauritsen N; Chiron R; Marchandin H
    Infect Genet Evol; 2015 Jun; 32():214-23. PubMed ID: 25791931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragenomic and intraspecific heterogeneity of the 16S rRNA gene in seven bacterial species from the respiratory tract of cystic fibrosis patients assessed by PCR-Temporal Temperature Gel Electrophoresis.
    Michon AL; Jumas-Bilak E; Imbert A; Aleyrangues L; Counil F; Chiron R; Marchandin H
    Pathol Biol (Paris); 2012 Jun; 60(3):e30-5. PubMed ID: 21621347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.
    Filipic B; Malesevic M; Vasiljevic Z; Lukic J; Novovic K; Kojic M; Jovcic B
    Front Cell Infect Microbiol; 2017; 7():224. PubMed ID: 28611955
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of High Diversity of Achromobacter Populations within Cystic Fibrosis Sputum Samples on Antimicrobial Susceptibility Testing.
    Dupont C; Jumas-Bilak E; Michon AL; Chiron R; Marchandin H
    J Clin Microbiol; 2017 Jan; 55(1):206-215. PubMed ID: 27807149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of
    Veschetti L; Sandri A; Patuzzo C; Melotti P; Malerba G; Lleo MM
    Microb Genom; 2021 Jul; 7(7):. PubMed ID: 34292148
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 7. Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina.
    Papalia M; Steffanowski C; Traglia G; Almuzara M; Martina P; Galanternik L; Vay C; Gutkind G; Ramírez MS; Radice M
    Rev Argent Microbiol; 2020; 52(1):13-18. PubMed ID: 31253503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among Cystic Fibrosis patients in the UK.
    Coward A; Kenna DT; Perry C; Martin K; Doumith M; Turton JF
    J Cyst Fibros; 2016 Jul; 15(4):479-85. PubMed ID: 26412052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Rodrigues ER; Ferreira AG; Leão RS; Leite CC; Carvalho-Assef AP; Albano RM; Marques EA
    J Clin Microbiol; 2015 Dec; 53(12):3894-6. PubMed ID: 26400790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and distribution of Achromobacter species in cystic fibrosis.
    Spilker T; Vandamme P; Lipuma JJ
    J Cyst Fibros; 2013 May; 12(3):298-301. PubMed ID: 23141756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplex real-time PCR assay for the simultaneous detection of
    Price EP; Soler Arango V; Kidd TJ; Fraser TA; Nguyen TK; Bell SC; Sarovich DS
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32667877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.
    Edwards BD; Greysson-Wong J; Somayaji R; Waddell B; Whelan FJ; Storey DG; Rabin HR; Surette MG; Parkins MD
    J Clin Microbiol; 2017 Jul; 55(7):2074-2085. PubMed ID: 28446570
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
    Amoureux L; Bador J; Siebor E; Taillefumier N; Fanton A; Neuwirth C
    J Cyst Fibros; 2013 Mar; 12(2):170-6. PubMed ID: 22944724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137.
    Amoureux L; Sauge J; Sarret B; Lhoumeau M; Bajard A; Tetu J; Bador J; Neuwirth C;
    J Cyst Fibros; 2019 Nov; 18(6):804-807. PubMed ID: 31104975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients.
    Rodrigues ER; Rocha GA; Ferreira AG; Leão RS; Albano RM; Marques EA
    Mem Inst Oswaldo Cruz; 2016 Dec; 111(12):777-780. PubMed ID: 27812598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genome characterization of Achromobacter members reveals potential genetic determinants facilitating the adaptation to a pathogenic lifestyle.
    Li X; Hu Y; Gong J; Zhang L; Wang G
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6413-25. PubMed ID: 23749121
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gabrielaite M; Nielsen FC; Johansen HK; Marvig RL
    Microb Genom; 2021 Jul; 7(7):. PubMed ID: 34232117
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains.
    Jean-Pierre V; Sorlin P; Pantel A; Chiron R; Lavigne JP; Jeannot K; Marchandin H;
    Ann Clin Microbiol Antimicrob; 2024 Jun; 23(1):54. PubMed ID: 38886694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.